Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer


Molecular prognostic markers are urgently needed in order to improve therapy decisions in prostate cancer. To better understand the requirements for biomarker studies, we re-analyzed prostate cancer tissue microarray immunohistochemistry (IHC) data from 39 prognosis markers in subsets of 50 - >10,000 tumors. We found a strong association between the… (More)
DOI: 10.3390/microarrays3020137


13 Figures and Tables